AAAAAA

   
Results: 1-23 |
Results: 23
LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis
Authors: Zhou, XH Caligiuri, G Hamsten, A Lefvert, AK Hansson, GK
Citation: Xh. Zhou et al., LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis, ART THROM V, 21(1), 2001, pp. 108-114
Circulating immune complexes induced by food proteins implicated in precocious myocardial infarction
Authors: Mustafa, A Hamsten, A Holm, G Lefvert, AK
Citation: A. Mustafa et al., Circulating immune complexes induced by food proteins implicated in precocious myocardial infarction, ANN MED, 33(2), 2001, pp. 103-112
Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells
Authors: Wang, XB Zheng, CY Giscombe, R Lefvert, AK
Citation: Xb. Wang et al., Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells, SC J IMMUN, 54(5), 2001, pp. 453-458
Re: Anticardiolipin antibodies are not an independent risk factor for stroke - Response
Authors: Lefvert, AK
Citation: Ak. Lefvert, Re: Anticardiolipin antibodies are not an independent risk factor for stroke - Response, STROKE, 32(5), 2001, pp. 1236-1236
Disruption of the IL-1 beta gene diminishes acetylcholine receptor-inducedimmune responses in a murine model of myasthenia gravis
Authors: Huang, DR Shi, FD Giscombe, R Zhou, YH Ljunggren, HG Lefvert, AK
Citation: Dr. Huang et al., Disruption of the IL-1 beta gene diminishes acetylcholine receptor-inducedimmune responses in a murine model of myasthenia gravis, EUR J IMMUN, 31(1), 2001, pp. 225-232
Immunological aspects of cardiovascular diseases - Introduction
Authors: Lefvert, AK Hansson, GK
Citation: Ak. Lefvert et Gk. Hansson, Immunological aspects of cardiovascular diseases - Introduction, J INTERN M, 247(3), 2000, pp. 348-348
Heterogeneity of autoantibodies against cardiolipin and oxidatively modified LDLs revealed by human monoclonal antibodies
Authors: Lefvert, AK
Citation: Ak. Lefvert, Heterogeneity of autoantibodies against cardiolipin and oxidatively modified LDLs revealed by human monoclonal antibodies, J INTERN M, 247(3), 2000, pp. 385-390
Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis
Authors: Huang, DR Giscombe, R Zhou, YH Pirskanen, R Lefvert, AK
Citation: Dr. Huang et al., Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis, J NEUROIMM, 105(1), 2000, pp. 69-77
Anticardiolipin antibodies are not an independent risk factor for stroke -An incident case-referent study nested within the MONICA and Vasterbotten Cohort Project
Authors: Ahmed, E Stegmayr, B Trifunovic, J Weinehall, L Hallmans, G Lefvert, AK
Citation: E. Ahmed et al., Anticardiolipin antibodies are not an independent risk factor for stroke -An incident case-referent study nested within the MONICA and Vasterbotten Cohort Project, STROKE, 31(6), 2000, pp. 1289-1293
beta(2)-adrenergic receptor gene polymorphisms in myasthenia gravis (MG)
Authors: Xu, BY Huang, D Pirskanen, R Lefvert, AK
Citation: By. Xu et al., beta(2)-adrenergic receptor gene polymorphisms in myasthenia gravis (MG), CLIN EXP IM, 119(1), 2000, pp. 156-160
Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction
Authors: Mustafa, A Nityanand, S Berglund, L Lithell, H Lefvert, AK
Citation: A. Mustafa et al., Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction, CIRCULATION, 102(21), 2000, pp. 2576-2581
Circulating immune complexes and complement C4 null alleles in patients operated on for premature atherosclerotic peripheral vascular disease
Authors: Nityanand, S Truedsson, L Mustafa, A Bergmark, C Lefvert, AK
Citation: S. Nityanand et al., Circulating immune complexes and complement C4 null alleles in patients operated on for premature atherosclerotic peripheral vascular disease, J CLIN IMM, 19(6), 1999, pp. 406-413
Antibody dependent cell-mediated cytotoxicity - an additional mechanism inhuman autoimmune myasthenia gravis
Authors: Xu, BY Pirskanen, R Lefvert, AK
Citation: By. Xu et al., Antibody dependent cell-mediated cytotoxicity - an additional mechanism inhuman autoimmune myasthenia gravis, J NEUROIMM, 99(2), 1999, pp. 183-188
Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease
Authors: Huang, DR Zhou, YH Xia, SQ Liu, L Pirskanen, R Lefvert, AK
Citation: Dr. Huang et al., Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease, J NEUROIMM, 94(1-2), 1999, pp. 82-87
Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis
Authors: Huang, DR Pirskanen, R Matell, G Lefvert, AK
Citation: Dr. Huang et al., Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis, J NEUROIMM, 94(1-2), 1999, pp. 165-171
Polymorphisms at-174 and in the 3 ' flanking region of interleukin-6 (IL-6) gene in patients with myasthenia gravis
Authors: Huang, DR Zheng, CY Giscombe, R Matell, G Pirskanen, R Lefvert, AK
Citation: Dr. Huang et al., Polymorphisms at-174 and in the 3 ' flanking region of interleukin-6 (IL-6) gene in patients with myasthenia gravis, J NEUROIMM, 101(2), 1999, pp. 197-200
Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke - A nested case-control study
Authors: Ahmed, E Trifunovic, J Stegmayr, B Hallmans, G Lefvert, AK
Citation: E. Ahmed et al., Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke - A nested case-control study, STROKE, 30(12), 1999, pp. 2541-2546
C4 null alleles and myocardial infarction
Authors: Nityanand, S Hamsten, A Lithell, H Holm, G Lefvert, AK
Citation: S. Nityanand et al., C4 null alleles and myocardial infarction, ATHEROSCLER, 143(2), 1999, pp. 377-381
Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications
Authors: Ahmed, E Nityanand, S Mustafa, A Brismar, K Lefvert, AK
Citation: E. Ahmed et al., Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications, CLIN EXP IM, 115(2), 1999, pp. 255-259
Expanded T cell populations in patients with Wegener's granulomatosis: Characteristics and correlates with disease activity
Authors: Giscombe, R Nityanand, S Lewin, N Grunewald, J Lefvert, AK
Citation: R. Giscombe et al., Expanded T cell populations in patients with Wegener's granulomatosis: Characteristics and correlates with disease activity, J CLIN IMM, 18(6), 1998, pp. 404-413
No evidence for interleukin-4 gene conferring susceptibility to myastheniagravis
Authors: Huang, DR Xia, SQ Zhou, YH Pirskanen, R Liu, L Lefvert, AK
Citation: Dr. Huang et al., No evidence for interleukin-4 gene conferring susceptibility to myastheniagravis, J NEUROIMM, 92(1-2), 1998, pp. 208-211
Antibodies against beta 1 and beta 2 adrenergic receptors in myasthenia gravis
Authors: Xu, BY Pirskanen, R Lefvert, AK
Citation: By. Xu et al., Antibodies against beta 1 and beta 2 adrenergic receptors in myasthenia gravis, J NEUROIMM, 91(1-2), 1998, pp. 82-88
Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis
Authors: Broome, U Hultcrantz, R Lefvert, AK Yi, Q
Citation: U. Broome et al., Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis, DIS COL REC, 41(12), 1998, pp. 1543-1549
Risultati: 1-23 |